TY - JOUR
T1 - Perspective Piece
T2 - Application of the relationship-based model to engagement for field trials of genetically engineered malaria vectors
AU - Kormos, Ana
AU - Lanzaro, Gregory C.
AU - Bier, Ethan
AU - Dimopoulos, George
AU - Marshall, John M.
AU - Pinto, João
AU - dos Santos, Adionilde Aguiar
AU - Bacar, Affane
AU - Rompão, Herodes Sousa Pontes Sacramento
AU - James, Anthony A.
N1 - Funding Information:
Other considerations. Funding. Early availability of funding and support from funders to conduct relationship-based engagement activities is essential for success of the program. Engagement should begin at the onset of the program, and to successfully engage with stakeholders and community members as outlined here, it is critical that a sufficient part of the program budget is allocated to these efforts over the entire course of the program.
Publisher Copyright:
Copyright © 2021 by The American Society of Tropical Medicine and Hygiene
PY - 2021/3
Y1 - 2021/3
N2 - The transition of new technologies for public health from laboratory to field is accompanied by a broadening scope of engagement challenges. Recent developments of vector control strategies involving genetically engineered mosquitoes with gene drives to assist in the eradication of malaria have drawn significant attention. Notably, questions have arisen surrounding community and regulatory engagement activities and of the need for examples of models or frameworks that can be applied to guide engagement. A relationship-based model (RBM) provides a framework that places stakeholders and community members at the center of decision-making processes, rather than as recipients of predetermined strategies, methods, and definitions. Successful RBM application in the transformation of healthcare delivery has demonstrated the importance of open dialogue and relationship development in establishing an environment where individuals are actively engaged in decision-making processes regarding their health. Although guidelines and recommendations for engagement for gene drives have recently been described, we argue here that communities and stakeholders should lead the planning, development, and implementation phases of engagement. The RBM provides a new approach to the development of ethical, transparent, and effective engagement strategies for malaria control programs.
AB - The transition of new technologies for public health from laboratory to field is accompanied by a broadening scope of engagement challenges. Recent developments of vector control strategies involving genetically engineered mosquitoes with gene drives to assist in the eradication of malaria have drawn significant attention. Notably, questions have arisen surrounding community and regulatory engagement activities and of the need for examples of models or frameworks that can be applied to guide engagement. A relationship-based model (RBM) provides a framework that places stakeholders and community members at the center of decision-making processes, rather than as recipients of predetermined strategies, methods, and definitions. Successful RBM application in the transformation of healthcare delivery has demonstrated the importance of open dialogue and relationship development in establishing an environment where individuals are actively engaged in decision-making processes regarding their health. Although guidelines and recommendations for engagement for gene drives have recently been described, we argue here that communities and stakeholders should lead the planning, development, and implementation phases of engagement. The RBM provides a new approach to the development of ethical, transparent, and effective engagement strategies for malaria control programs.
UR - http://www.scopus.com/inward/record.url?scp=85103264018&partnerID=8YFLogxK
U2 - 10.4269/ajtmh.20-0868
DO - 10.4269/ajtmh.20-0868
M3 - Review article
C2 - 33350374
AN - SCOPUS:85103264018
SN - 0002-9637
VL - 104
SP - 805
EP - 811
JO - American Journal of Tropical Medicine and Hygiene
JF - American Journal of Tropical Medicine and Hygiene
IS - 3
ER -